Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer. (2017)
Attributed to:
Establishment of the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF]
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-16-2546
PubMed Identifier: 28455421
Publication URI: http://europepmc.org/abstract/MED/28455421
Type: Journal Article/Review
Volume: 77
Parent Publication: Cancer research
Issue: 14
ISSN: 0008-5472